AngioDynamics, Inc. (ANGO)

Import this data to Google Sheets with:

=jivedata("ANGO","financials")

Full statements spill as a table. For one cell: =jivedata("ANGO","Revenue") or =jivedata("ANGO","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

AngioDynamics, Inc.

ANGO • CIK 0001275187

(in thousands, except per share data)	FY 2024	FY 2025	FY 2026	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$303,914	$292,498	$320,174	$320,174
Cost of Goods and Services Sold	$149,216	$134,793	$145,282	$145,282
Gross Profit	$154,698	$157,705	$174,892	$174,892
Operating Income (Loss)	$-192,435	$-39,954	$-39,927	$-39,927
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-191,638	$-34,032	$-36,300	$-36,300
Income Tax Expense (Benefit)	$-7,289	$-39	$442	$442
Net Income (Loss) Attributable to Parent	$-184,349	$-33,993	$-36,742	$-36,742
Research and Development Expense	$31,512	$26,222	$29,447	$29,447
Selling and Marketing Expense	$102,818	$103,135	$113,401	$113,401
General and Administrative Expense	$41,164	$42,092	$43,691	$43,691
Amortization of Intangible Assets	$13,048	$10,318	$10,682	$10,682
Goodwill, Impairment Loss	$159,476	$0	$0	$0
Operating Expenses	$401,632	$197,659	$214,819	$214,819
Gain (Loss) on Disposition of Assets	$54,499	$0	$0	$0
Interest Income (Expense), Nonoperating, Net	—	$978	$-299	$-299
Other Nonoperating Income (Expense)	$-817	$4,944	$3,926	$3,926
Weighted Average Number of Shares Outstanding, Basic	40,180,925	40,852,564	41,525,697	41,525,697
Weighted Average Number Diluted Shares Outstanding Adjustment	0	0	0	0
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	3,973,382	5,121,073	5,912,410	5,912,410
Operating Lease, Expense	$2,549	$2,632	$2,345	$2,345

(in thousands, except per share data)	FY 2024	FY 2025	FY 2026	TTM
Cash and Cash Equivalents, at Carrying Value	$76,056	$55,893	$53,864	$53,864
Accounts Receivable, after Allowance for Credit Loss, Current	$43,610	$42,890	$48,325	$48,325
Property, Plant and Equipment, Net	$35,666	$32,300	$27,097	$27,097
Inventory, Net	$60,616	$62,006	$52,436	$52,436
Intangible Assets, Net (Excluding Goodwill)	$77,383	$69,116	$67,209	$67,209
Treasury Stock, Common, Shares	370,000,000	370,000,000	613,847	613,847
Prepaid Expense and Other Assets, Current	$12,971	$7,535	$8,769	$8,769
Other Assets, Noncurrent	$11,369	$10,404	$9,463	$9,463
Assets, Current	$193,253	$168,324	$163,394	$163,394
Assets	$317,671	$280,144	$267,163	$267,163
Deferred Income Taxes and Other Tax Liabilities, Noncurrent	$4,852	$4,073	$5,316	$5,316
Other Liabilities, Noncurrent	$16,078	$16,904	$16,305	$16,305
Liabilities	$112,085	$97,174	$96,338	$96,338
Accounts Payable, Current	$37,751	$33,291	$31,513	$31,513
Accrued Liabilities, Current	$41,098	$35,518	$38,909	$38,909
Other Liabilities, Current	$7,578	$7,388	$4,295	$4,295
Liabilities, Current	$91,155	$76,197	$74,717	$74,717
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$385	$385	$387	$387
Additional Paid in Capital, Common Stock	$610,484	$621,186	$636,083	$636,083
Retained Earnings (Accumulated Deficit)	$-395,204	$-429,197	$-465,939	$-465,939
Treasury Stock, Value	$5,714	$7,381	$7,381	$7,381
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-4,365	$-2,023	$7,675	$7,675
Stockholders' Equity Attributable to Parent	$205,586	$182,970	$170,825	$170,825
Accounts Receivable, Allowance for Credit Loss, Current	$2,141	$2,215	$1,851	$1,851
Preferred Stock, Shares Authorized	5,000,000	5,000,000	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	75,000,000	75,000,000	75,000,000	75,000,000
Common Stock, Shares, Issued	40,801,597	41,607,877	42,314,266	42,314,266
Common Stock, Shares, Outstanding	40,431,597	40,994,030	41,700,419	41,700,419
Operating Lease, Right-of-Use Asset	$5,804	$3,850	$5,053	$5,053
Operating Lease, Liability, Current	$1,975	$1,840	$1,296	$1,296
Operating Lease, Liability, Noncurrent	$3,939	$2,106	$3,860	$3,860
Operating Lease, Liability	$5,914	$3,946	$5,156	$5,156

(in thousands, except per share data)	FY 2024	FY 2025	FY 2026	TTM
Net Income (Loss) Attributable to Parent	$-184,349	$-33,993	$-36,742	$-36,742
Net Cash Provided by (Used in) Operating Activities	$-28,158	$-10,128	$3,089	$3,089
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$125	$398	$267	$267
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$31,436	$-20,163	$-2,029	$-2,029
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$76,056	$55,893	$53,864	$53,864
Depreciation, Depletion and Amortization, Nonproduction	$27,712	$25,800	$22,955	$22,955
Payments to Acquire Property, Plant, and Equipment	$2,518	$4,464	$2,581	$2,581
Proceeds from Divestiture of Businesses	$134,500	$0	$0	$0
Goodwill, Impairment Loss	$159,476	$0	$0	$0
Share-based Payment Arrangement, Noncash Expense	$10,529	$9,772	$13,960	$13,960
Net Cash Provided by (Used in) Investing Activities	$123,717	$-10,178	$-5,949	$-5,949
Gain (Loss) on Disposition of Business	$54,499	$0	$0	$0
Accounts Receivable, Credit Loss Expense (Reversal)	$1,326	$699	$313	$313
Impairment of Long-Lived Assets Held-for-use	$7,108	$173	$1,304	$1,304
Other Asset Impairment Charges	$869	$0	$0	$0
Other Noncash Income (Expense)	$62	$-291	$-1,969	$-1,969
Repayments of Long-term Debt	$50,000	$0	$0	$0
Payments of Debt Issuance Costs	$0	$680	$0	$0
Finance Lease, Principal Payments	—	$148	$375	$375
Proceeds from Issuance of Secured Debt	—	$6,310	$0	$0
Payment for Contingent Consideration Liability, Financing Activities	$15,000	$5,000	$0	$0
Payments for Repurchase of Common Stock	—	$1,670	$0	$0
Net Cash Provided by (Used in) Financing Activities	$-64,248	$-255	$564	$564
Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed)	$-78	$-49	$-68	$-68
Interest Paid, Including Capitalized Interest, Operating and Investing Activities	$0	$185	$426	$426
Income Taxes Paid, Net	$455	$800	$405	$405
Increase (Decrease) in Accounts Receivable	$-7,894	$-23	$5,750	$5,750
Increase (Decrease) in Inventories	$9,410	$1,347	$-10,047	$-10,047
Increase (Decrease) in Prepaid Expense and Other Assets	$11,594	$-3,089	$1,122	$1,122
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$27,531	$-15,877	$-5,833	$-5,833

Jive Data

Google Sheets add-onSheets Account

Import this data to Google Sheets with:

=jivedata("ANGO","financials")

Full statements spill as a table. For one cell: =jivedata("ANGO","Revenue") or =jivedata("ANGO","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

AngioDynamics, Inc.

ANGO • CIK 0001275187

(in thousands, except per share data)	FY 2024	FY 2025	FY 2026	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$303,914	$292,498	$320,174	$320,174
Cost of Goods and Services Sold	$149,216	$134,793	$145,282	$145,282
Gross Profit	$154,698	$157,705	$174,892	$174,892
Operating Income (Loss)	$-192,435	$-39,954	$-39,927	$-39,927
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-191,638	$-34,032	$-36,300	$-36,300
Income Tax Expense (Benefit)	$-7,289	$-39	$442	$442
Net Income (Loss) Attributable to Parent	$-184,349	$-33,993	$-36,742	$-36,742
Research and Development Expense	$31,512	$26,222	$29,447	$29,447
Selling and Marketing Expense	$102,818	$103,135	$113,401	$113,401
General and Administrative Expense	$41,164	$42,092	$43,691	$43,691
Amortization of Intangible Assets	$13,048	$10,318	$10,682	$10,682
Goodwill, Impairment Loss	$159,476	$0	$0	$0
Operating Expenses	$401,632	$197,659	$214,819	$214,819
Gain (Loss) on Disposition of Assets	$54,499	$0	$0	$0
Interest Income (Expense), Nonoperating, Net	—	$978	$-299	$-299
Other Nonoperating Income (Expense)	$-817	$4,944	$3,926	$3,926
Weighted Average Number of Shares Outstanding, Basic	40,180,925	40,852,564	41,525,697	41,525,697
Weighted Average Number Diluted Shares Outstanding Adjustment	0	0	0	0
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	3,973,382	5,121,073	5,912,410	5,912,410
Operating Lease, Expense	$2,549	$2,632	$2,345	$2,345

(in thousands, except per share data)	FY 2024	FY 2025	FY 2026	TTM
Cash and Cash Equivalents, at Carrying Value	$76,056	$55,893	$53,864	$53,864
Accounts Receivable, after Allowance for Credit Loss, Current	$43,610	$42,890	$48,325	$48,325
Property, Plant and Equipment, Net	$35,666	$32,300	$27,097	$27,097
Inventory, Net	$60,616	$62,006	$52,436	$52,436
Intangible Assets, Net (Excluding Goodwill)	$77,383	$69,116	$67,209	$67,209
Treasury Stock, Common, Shares	370,000,000	370,000,000	613,847	613,847
Prepaid Expense and Other Assets, Current	$12,971	$7,535	$8,769	$8,769
Other Assets, Noncurrent	$11,369	$10,404	$9,463	$9,463
Assets, Current	$193,253	$168,324	$163,394	$163,394
Assets	$317,671	$280,144	$267,163	$267,163
Deferred Income Taxes and Other Tax Liabilities, Noncurrent	$4,852	$4,073	$5,316	$5,316
Other Liabilities, Noncurrent	$16,078	$16,904	$16,305	$16,305
Liabilities	$112,085	$97,174	$96,338	$96,338
Accounts Payable, Current	$37,751	$33,291	$31,513	$31,513
Accrued Liabilities, Current	$41,098	$35,518	$38,909	$38,909
Other Liabilities, Current	$7,578	$7,388	$4,295	$4,295
Liabilities, Current	$91,155	$76,197	$74,717	$74,717
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$385	$385	$387	$387
Additional Paid in Capital, Common Stock	$610,484	$621,186	$636,083	$636,083
Retained Earnings (Accumulated Deficit)	$-395,204	$-429,197	$-465,939	$-465,939
Treasury Stock, Value	$5,714	$7,381	$7,381	$7,381
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-4,365	$-2,023	$7,675	$7,675
Stockholders' Equity Attributable to Parent	$205,586	$182,970	$170,825	$170,825
Accounts Receivable, Allowance for Credit Loss, Current	$2,141	$2,215	$1,851	$1,851
Preferred Stock, Shares Authorized	5,000,000	5,000,000	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	75,000,000	75,000,000	75,000,000	75,000,000
Common Stock, Shares, Issued	40,801,597	41,607,877	42,314,266	42,314,266
Common Stock, Shares, Outstanding	40,431,597	40,994,030	41,700,419	41,700,419
Operating Lease, Right-of-Use Asset	$5,804	$3,850	$5,053	$5,053
Operating Lease, Liability, Current	$1,975	$1,840	$1,296	$1,296
Operating Lease, Liability, Noncurrent	$3,939	$2,106	$3,860	$3,860
Operating Lease, Liability	$5,914	$3,946	$5,156	$5,156

(in thousands, except per share data)	FY 2024	FY 2025	FY 2026	TTM
Net Income (Loss) Attributable to Parent	$-184,349	$-33,993	$-36,742	$-36,742
Net Cash Provided by (Used in) Operating Activities	$-28,158	$-10,128	$3,089	$3,089
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$125	$398	$267	$267
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$31,436	$-20,163	$-2,029	$-2,029
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$76,056	$55,893	$53,864	$53,864
Depreciation, Depletion and Amortization, Nonproduction	$27,712	$25,800	$22,955	$22,955
Payments to Acquire Property, Plant, and Equipment	$2,518	$4,464	$2,581	$2,581
Proceeds from Divestiture of Businesses	$134,500	$0	$0	$0
Goodwill, Impairment Loss	$159,476	$0	$0	$0
Share-based Payment Arrangement, Noncash Expense	$10,529	$9,772	$13,960	$13,960
Net Cash Provided by (Used in) Investing Activities	$123,717	$-10,178	$-5,949	$-5,949
Gain (Loss) on Disposition of Business	$54,499	$0	$0	$0
Accounts Receivable, Credit Loss Expense (Reversal)	$1,326	$699	$313	$313
Impairment of Long-Lived Assets Held-for-use	$7,108	$173	$1,304	$1,304
Other Asset Impairment Charges	$869	$0	$0	$0
Other Noncash Income (Expense)	$62	$-291	$-1,969	$-1,969
Repayments of Long-term Debt	$50,000	$0	$0	$0
Payments of Debt Issuance Costs	$0	$680	$0	$0
Finance Lease, Principal Payments	—	$148	$375	$375
Proceeds from Issuance of Secured Debt	—	$6,310	$0	$0
Payment for Contingent Consideration Liability, Financing Activities	$15,000	$5,000	$0	$0
Payments for Repurchase of Common Stock	—	$1,670	$0	$0
Net Cash Provided by (Used in) Financing Activities	$-64,248	$-255	$564	$564
Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed)	$-78	$-49	$-68	$-68
Interest Paid, Including Capitalized Interest, Operating and Investing Activities	$0	$185	$426	$426
Income Taxes Paid, Net	$455	$800	$405	$405
Increase (Decrease) in Accounts Receivable	$-7,894	$-23	$5,750	$5,750
Increase (Decrease) in Inventories	$9,410	$1,347	$-10,047	$-10,047
Increase (Decrease) in Prepaid Expense and Other Assets	$11,594	$-3,089	$1,122	$1,122
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$27,531	$-15,877	$-5,833	$-5,833

AngioDynamics, Inc.

Consolidated Statementsof Operations

Consolidated Balance Sheets

Consolidated Statementsof Cash Flows

AngioDynamics, Inc.

Consolidated Statementsof Operations

Consolidated Balance Sheets

Consolidated Statementsof Cash Flows